Reuters logo
BRIEF-AbbVie, on conf call, says we need to see HCV market sort itself out
October 27, 2017 / 4:35 PM / 25 days ago

BRIEF-AbbVie, on conf call, says we need to see HCV market sort itself out

Oct 27 (Reuters) - Abbvie Inc:

* AbbVie CEO, on conf call, says we need to see HCV market sort itself out

* AbbVie CEO, on conf call, says psoriasis business &, in general, areas where humira competes, has been and continues to be a relatively crowded market

* AbbVie CEO, on conf call, says humira will still be a workhorse product within the psoriasis market, and risankizumab will fit in

* AbbVie CEO, on conf call, says we would attempt to get a preliminary injunction to block any launches that violate our Humira IP ‍​

* AbbVie, on conf call, says upadacitinib NDA next year will be filed with at least five of six studies ‍​ Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below